These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 27513462)
1. MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells. Vanas V; Haigl B; Stockhammer V; Sutterlüty-Fall H PLoS One; 2016; 11(8):e0161023. PubMed ID: 27513462 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells. Zhou X; Natino D; Zhai X; Gao Z; He X Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma. Zhou C; Tan W; Lv H; Gao F; Sun J Cell Oncol (Dordr); 2016 Oct; 39(5):463-471. PubMed ID: 27376839 [TBL] [Abstract][Full Text] [Related]
4. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma. Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504 [TBL] [Abstract][Full Text] [Related]
5. Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma. Hu Y; Gu J; Shen H; Shao T; Li S; Wang W; Yu Z J Clin Lab Anal; 2020 Feb; 34(2):e23045. PubMed ID: 31642110 [TBL] [Abstract][Full Text] [Related]
6. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2. Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321 [TBL] [Abstract][Full Text] [Related]
7. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells. Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis. Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma. Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate. Jiang L; Tao C; He A; He X World J Surg Oncol; 2014 Dec; 12():383. PubMed ID: 25510179 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma. Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990 [TBL] [Abstract][Full Text] [Related]
12. Identification of drug-regulated genes in osteosarcoma cells. Fellenberg J; Dechant MJ; Ewerbeck V; Mau H Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912 [TBL] [Abstract][Full Text] [Related]
13. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene. Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1. Zhang Y; Duan G; Feng S Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line. Ziyan W; Yang L Ir J Med Sci; 2016 Feb; 185(1):85-91. PubMed ID: 25381586 [TBL] [Abstract][Full Text] [Related]
16. Roles of microRNA-22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin-mediated Autophagy. Wang P; Zhao ZQ; Guo SB; Yang TY; Chang ZQ; Li DH; Zhao W; Wang YX; Sun C; Wang Y; Feng W Orthop Surg; 2019 Apr; 11(2):285-293. PubMed ID: 30932352 [TBL] [Abstract][Full Text] [Related]
17. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma. Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083 [TBL] [Abstract][Full Text] [Related]
18. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855 [TBL] [Abstract][Full Text] [Related]
19. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma. Tsai HC; Huang CY; Su HL; Tang CH PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722 [TBL] [Abstract][Full Text] [Related]
20. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression. Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]